Juan Córdoba
Research Subjects
Juan Córdoba has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Juli Alonso
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain
6 shared publications- Laia Chavarria
Liver Unit, Hospital Vall Hebron, Barcelona, Spain
6 shared publications - Rita García-Martínez
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain
6 shared publications Alex Rovira
Magnetic Resonance Unit (IDI), Department of Radiology, Hospital d'Vall Hebron, Barcelona, Spain
5 shared publicationsMacarena Simón-Talero
Hospital Vall d'Hebron, Department of Medicine, Liver Unit, Universitat Autònoma de Barcelona, Spain
5 shared publications- Victor Vargas
Liver Unit, Department of Medicine Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona Barcelona Spain
4 shared publications
Latest Publications
- 1 March 2015
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 5, S69-S74
Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy
- 1 March 2015
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 5, S69-S74
Magnetic Resonance Imaging and Spectroscopy in Hepatic Encephalopathy
- Open Access
- 4 June 2014
- Published by Hindawi Limited in ISRN Hepatology
- Vol. 2014, 1-16
Hepatic Encephalopathy: From the Pathogenesis to the New Treatments
Hepatic encephalopathy is a frequent and serious complication of liver cirrhosis; the pathophysiology of this complication is not fully understood although great efforts have been made during the last years. There are few prospective studies on the epidemiology of this complication; however, it is known that it confers with high short-term mortality. Hepatic encephalopathy has been classified into different groups depending on the degree of hepatic dysfunction, the presence of portal-systemic shunts, and the number of episodes. Due to the large clinical spectra of overt EH and the complexity of cirrhotic patients, it is very difficult to perform quality clinical trials for assessing the efficacy of the treatments proposed. The physiopathology, clinical manifestation, and the treatment of HE is a challenge because of the multiple factors that converge and coexist in an episode of overt HE.
- 4 June 2014
- Published by Hindawi Limited in ISRN Hepatology
- Vol. 2014, 1-16
Open AccessHepatic Encephalopathy: From the Pathogenesis to the New Treatments
Hepatic encephalopathy is a frequent and serious complication of liver cirrhosis; the pathophysiology of this complication is not fully understood although great efforts have been made during the last years. There are few prospective studies on the epidemiology of this complication; however, it is known that it confers with high short-term mortality. Hepatic encephalopathy has been classified into different groups depending on the degree of hepatic dysfunction, the presence of portal-systemic shunts, and the number of episodes. Due to the large clinical spectra of overt EH and the complexity of cirrhotic patients, it is very difficult to perform quality clinical trials for assessing the efficacy of the treatments proposed. The physiopathology, clinical manifestation, and the treatment of HE is a challenge because of the multiple factors that converge and coexist in an episode of overt HE.
- Top Cited Papers
- 1 February 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (2) , 275-281
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)
- 1 February 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (2) , 275-281
Top Cited PapersCharacteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)
- 21 November 2013
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 29 (4) , 937-944
Magnetic resonance of the brain in chronic and acute liver failure
Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging methods allow a non-invasive assessment of brain alterations in liver failure. Magnetic resonance has gained more interest due to the ability of giving information about cerebral metabolism using spectroscopy, water distribution by diffusion methods or neuronal connectivity by means of resting state magnetic resonance. These techniques have been applied to experimental models and patients with liver failure to elucidate cerebral pathways involved in the pathogenesis of hepatic encephalopathy. In the future, the development of new magnetic resonance implementations will generate handy tools for the study of the brain and get better understanding of the mechanisms that take place in liver failure. This could be useful for the early diagnosis, as well as for the design of new treatments for cerebral complications of liver failure.
- 21 November 2013
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 29 (4) , 937-944
Magnetic resonance of the brain in chronic and acute liver failure
Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging methods allow a non-invasive assessment of brain alterations in liver failure. Magnetic resonance has gained more interest due to the ability of giving information about cerebral metabolism using spectroscopy, water distribution by diffusion methods or neuronal connectivity by means of resting state magnetic resonance. These techniques have been applied to experimental models and patients with liver failure to elucidate cerebral pathways involved in the pathogenesis of hepatic encephalopathy. In the future, the development of new magnetic resonance implementations will generate handy tools for the study of the brain and get better understanding of the mechanisms that take place in liver failure. This could be useful for the early diagnosis, as well as for the design of new treatments for cerebral complications of liver failure.
- Open Access
- 9 October 2013
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (3) , 764-766
Drug-induced removal of nitrogen derivatives in urine: A new concept whose time has come
- 9 October 2013
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (3) , 764-766
Open AccessDrug-induced removal of nitrogen derivatives in urine: A new concept whose time has come
- Open Access
- 1 January 2013
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 105 (1) , 51
Encefalopatía hepática
- 1 January 2013
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 105 (1) , 51
Open AccessEncefalopatía hepática
- Open Access
- 21 November 2012
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 33 (2) , 272-277
Brain Magnetic Resonance Spectroscopy in Episodic Hepatic Encephalopathy
Brain magnetic resonance (MR) study has shown metabolic abnormalities and changes in water distribution of the brain tissue that may relate to the pathogenesis of hepatic encephalopathy (HE). We designed a study to investigate the disturbances in brain water and metabolites during episodic HE using a 3-T MR scanner. Cirrhotic patients with different grades of HE underwent MR during hospitalization ( n = 18). The MR was repeated at 6 weeks' follow-up ( n = 14). The results were compared with those of a group of healthy volunteers ( n = 8). During episodic HE, brain diffusion-weighted imaging showed a high apparent diffusion coefficient (ADC) (12% to 14%) that decreased during follow-up (–1% to −4%). These disturbances were accompanied by high glutamine (581%), low choline (–31%), and low myo-inositol (–86%) peaks on MR spectroscopy. In overt HE, patients showed high glutamine that decreased during follow-up (–22%). In addition, these patients exhibited a rise in plasma S100 beta and enlargement of brain white-matter lesions. In conclusion, several disturbances detected by MR support the presence of impaired brain water homeostasis during episodic HE. Although astrocytes have a major role in this condition, brain edema during episodic HE may be extracellular and does not appear to be directly responsible for the development of neurologic manifestations.
- 21 November 2012
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 33 (2) , 272-277
Open AccessBrain Magnetic Resonance Spectroscopy in Episodic Hepatic Encephalopathy
Brain magnetic resonance (MR) study has shown metabolic abnormalities and changes in water distribution of the brain tissue that may relate to the pathogenesis of hepatic encephalopathy (HE). We designed a study to investigate the disturbances in brain water and metabolites during episodic HE using a 3-T MR scanner. Cirrhotic patients with different grades of HE underwent MR during hospitalization ( n = 18). The MR was repeated at 6 weeks' follow-up ( n = 14). The results were compared with those of a group of healthy volunteers ( n = 8). During episodic HE, brain diffusion-weighted imaging showed a high apparent diffusion coefficient (ADC) (12% to 14%) that decreased during follow-up (–1% to −4%). These disturbances were accompanied by high glutamine (581%), low choline (–31%), and low myo-inositol (–86%) peaks on MR spectroscopy. In overt HE, patients showed high glutamine that decreased during follow-up (–22%). In addition, these patients exhibited a rise in plasma S100 beta and enlargement of brain white-matter lesions. In conclusion, several disturbances detected by MR support the presence of impaired brain water homeostasis during episodic HE. Although astrocytes have a major role in this condition, brain edema during episodic HE may be extracellular and does not appear to be directly responsible for the development of neurologic manifestations.
- 16 November 2012
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 28 (2) , 285-292
Encephalopathy and liver transplantation
Liver transplantation (LT) candidates experience frequently episodic or persistent hepatic encephalopathy. In addition, these patients can exhibit neurological comorbidities that contribute to cognitive impairment in the pre-transplant period. Assessment of the respective contribution of hepatic encephalopathy or comorbidities in the cognitive manifestations is critical to estimate the neurological benefits of restoring liver function. Magnetic resonance imaging and spectroscopy are useful to assess the impact of liver failure or comorbidities. This assessment is critical to decide liver transplant in difficult cases. In the early postoperative period, LT is commonly complicated by a confusional syndrome. The possible role of persisting hepatic encephalopathy in its development has not been clearly established. The origin is usually considered multifactorial and relates to complications following LT, such as infections, rejection, primary liver dysfunction, immunosuppressors, etc.… The diagnosis and treatment is based in the recognition of comorbidities and optimal care of metabolic disturbances. Several studies have demonstrated recovery of cognitive function after LT in patients that have exhibited hepatic encephalopathy. However, some deficits may persist specifically among patients with persistent HE. Other factors present before LT that contribute to a worse neuropsychological outcome after LT are diabetes mellitus and alcohol consumption. Long-term after LT, cognitive function may worsen in relation to vascular risk factors.
- 16 November 2012
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 28 (2) , 285-292
Encephalopathy and liver transplantation
Liver transplantation (LT) candidates experience frequently episodic or persistent hepatic encephalopathy. In addition, these patients can exhibit neurological comorbidities that contribute to cognitive impairment in the pre-transplant period. Assessment of the respective contribution of hepatic encephalopathy or comorbidities in the cognitive manifestations is critical to estimate the neurological benefits of restoring liver function. Magnetic resonance imaging and spectroscopy are useful to assess the impact of liver failure or comorbidities. This assessment is critical to decide liver transplant in difficult cases. In the early postoperative period, LT is commonly complicated by a confusional syndrome. The possible role of persisting hepatic encephalopathy in its development has not been clearly established. The origin is usually considered multifactorial and relates to complications following LT, such as infections, rejection, primary liver dysfunction, immunosuppressors, etc.… The diagnosis and treatment is based in the recognition of comorbidities and optimal care of metabolic disturbances. Several studies have demonstrated recovery of cognitive function after LT in patients that have exhibited hepatic encephalopathy. However, some deficits may persist specifically among patients with persistent HE. Other factors present before LT that contribute to a worse neuropsychological outcome after LT are diabetes mellitus and alcohol consumption. Long-term after LT, cognitive function may worsen in relation to vascular risk factors.
- 26 October 2012
- Published by Wiley in Liver International
- Vol. 33 (2) , 294-300
Brain magnetic resonance in experimental acute‐on‐chronic liver failure
Background & Aim: Acute‐on‐chronic liver failure is the term that refers to sustained liver injury with acute decompensation, usually induced by a precipitating factor. A common link between ensuing failures of various organs is impairment of the vascular supply, which may also induce vasogenic oedema in the brain. The aim of this study was to perform magnetic resonance (MR) study of the brain in a rat model combining bile duct ligation (BDL) and lipopolysaccharide (LPS) administration to investigate brain oedema in liver failure.Methods: Bile duct‐ligated rats underwent in vivo brain MR imaging at 4, 5 and 6 weeks, and after superimposed administration of LPS. The MR techniques applied enabled assessment of brain metabolites, and intra‐ or extracellular water distribution. Brain water content was assessed by gravimetry.Results: MR spectroscopy showed an increase in brain glutamine and a decrease in myo‐inositol and choline in relation to progression of liver disease. BDL rats showed a slight, progressive increase in the amount of cortical brain water that was significant after LPS injection. These changes did not modify the apparent diffusion coefficient, supporting a mixed origin of brain oedema (vasogenic and cytotoxic).Conclusions: The mechanisms leading to the development of brain oedema in an experimental liver disease model were related to the time course of liver failure and to pro‐inflammatory stimuli. MR findings support the presence of cytotoxic and vasogenic mechanisms in induced brain oedema in BDL rats exposed to LPS.
- 26 October 2012
- Published by Wiley in Liver International
- Vol. 33 (2) , 294-300
Brain magnetic resonance in experimental acute‐on‐chronic liver failure
Background & Aim: Acute‐on‐chronic liver failure is the term that refers to sustained liver injury with acute decompensation, usually induced by a precipitating factor. A common link between ensuing failures of various organs is impairment of the vascular supply, which may also induce vasogenic oedema in the brain. The aim of this study was to perform magnetic resonance (MR) study of the brain in a rat model combining bile duct ligation (BDL) and lipopolysaccharide (LPS) administration to investigate brain oedema in liver failure.Methods: Bile duct‐ligated rats underwent in vivo brain MR imaging at 4, 5 and 6 weeks, and after superimposed administration of LPS. The MR techniques applied enabled assessment of brain metabolites, and intra‐ or extracellular water distribution. Brain water content was assessed by gravimetry.Results: MR spectroscopy showed an increase in brain glutamine and a decrease in myo‐inositol and choline in relation to progression of liver disease. BDL rats showed a slight, progressive increase in the amount of cortical brain water that was significant after LPS injection. These changes did not modify the apparent diffusion coefficient, supporting a mixed origin of brain oedema (vasogenic and cytotoxic).Conclusions: The mechanisms leading to the development of brain oedema in an experimental liver disease model were related to the time course of liver failure and to pro‐inflammatory stimuli. MR findings support the presence of cytotoxic and vasogenic mechanisms in induced brain oedema in BDL rats exposed to LPS.